Correvio
Correvio is a biopharmaceutical company that researches and develops cardiology products for the treatment of cardiovascular diseases.
Business Model:
Revenue: $28.3M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Correvio Information
Correvio was acquired by
Advanz Pharma.
The acquisition happend on 2020-03-16.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 1441 Creekside Drive
City: Vancouver
State: british columbia
Zip: V6J 4S7
Country: CA
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
4,204,197Website Global Rank
1,039Website Monthly Traffic
Twitter Followers
Description
Correvio is a biopharmaceutical company that researches and develops cardiology products for the treatment of cardiovascular diseases.
Contact Phone:
Contact Email:
Correvio went public on 9/13/1996 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
9/13/1996
Ticker Symbol:
CORV
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
